Monocyte-derived IP-10 has a major role in the pathogenesis of sustained/progressing phenotypes in Nakajo-Nishimura syndrome
2016; Elsevier BV; Volume: 84; Issue: 1 Linguagem: Inglês
10.1016/j.jdermsci.2016.08.287
ISSN1873-569X
AutoresNobuo Kanazawa, Yumi Nakatani, Yutaka Inaba, Kayo Kunimoto, Fukumi Furukawa, Fumiko Ozaki,
Tópico(s)Transplantation: Methods and Outcomes
ResumoIn Nakajo-Nishimura syndrome (NNS), proteasome disability due to a loss-of-function PSMB8 mutation induces storage of ubiquitinated proteins and overproduction of inflammatory cytokines and chemokines. However, the precise mechanisms causing complex phenotypes of the disease, including pernio-like eruptions, lipodystrophy and calcification of basal ganglia, is mostly unclear. As IL-6 overproduction in association with p38 hyperactivation was supposed to have a role in NNS (Arima et al., PNAS 2011), tocilizumab, a monoclonal antibody for IL-6 receptor, has recently been applied for two patients with NNS after informed consents were obtained. Decreased serum CRP and CPK levels in both patients and improved myalgia and arthralgia in one patient have been observed, whereas none of decrease in serum LDH level or improvement of fever and eruptions have been achieved. By analysis of serum cytokine/chemokine levels, IL-6, G-CSF and MCP-1 levels have changed in accordance to the CRP level, whereas interferon-induced protein (IP)-10 has shown constantly high levels independent of the CRP level. Furthermore, both the patients-derived peripheral blood monocytes and monocytes differentiated from a patient-derived induced pluripotent stem (iPS) cells similarly produced higher level of IP-10 than control cells after IFNγ stimulation. These findings suggest that monocyte-derived IP-10 has a major role in the pathogenesis of sustained/progressing phenotypes in NNS.
Referência(s)